March 28, 2023
Indian Pharma Post
Lupin receives tentative approval from USFDA for Valbenazine capsules
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVI... See more »
Dr.Reddy's: Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
(marketscreener.com) Dr. Reddy's Laboratories Ltd. today announced the launch of Dr. Reddy's Difluprednate Ophthalmic Emulsion 0.05%, a therapeutic generic equivalent to Durezol® in the U.S. market, following the approval by the U.S. Food and Drug Administration . The Durezol® brand and generic had U.S. sales of approximately $40 million MAT...https://www.marketscreener.com/quote/stock/DR-REDDY-S-LABORATORIES-6492671/news/Dr-Reddy-s-Laboratories-announces-the-launch-of-Difluprednate-Ophthalmic-Emulsion-0-05-in-the-U-S-42828171/?utm_medium=RSS&utm_content=20230127
Read full article »
March 28, 2023
centralcharts
RAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 19, 2023 in the Class Action Filed on Behalf of Rite Aid Corporation Shareholders
RAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 19, 2023 in the Class Action... See more »
March 27, 2023
MarketScreener
Taro Pharmaceutical Industries : Report Of Foreign Private Issuer - Form 6-K
(marketscreener.com) HAWTHORNE, N.Y., USA, March 27, 2023 ─ As previously disclosed, on March 1, 2023... See more »
March 27, 2023Insurance Journal
Ransomware Attack to Hit Revenue at India's Top Drugmaker
Sun Pharmaceutical Industries Ltd. expects revenue to fall as measures taken by India's top drugmaker... See more »
March 27, 2023Pharmabiz
Lupin announces completion of pharmacovigilance inspection by US FDA with no observations
Global pharma major Lupin Limited (Lupin) announced that the United States Food and Drug Administrati... See more »
March 27, 2023Mass Market Retailers
Andre Persaud leaves Rite Aid post
CAMP HILL, Pa. - Andre Persaud, chief retail officer at Rite Aid Corp., left the company earlier this... See more »
March 27, 2023Techstory
Sun Pharma says business affected due to ransomware attack on March 2 The ransomware incident has disrupted Sun Pharma's business activities.
The biggest pharmaceutical company in India, Sun Pharmaceuticals Industries Ltd., revealed that a rec... See more »
March 27, 2023The Economic Times
Lupin gets tentative USFDA approval to market generic valbenazine capsules
These are the generic equivalent of Ingrezza capsules, 40 mg, 60 mg, and 80 mg, of Neurocrine Bioscie... See more »
March 28, 2023
Indian Pharma Post
Lupin receives tentative approval from USFDA for Valbenazine capsules
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVI... See more »
March 28, 2023
centralcharts
RAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 19, 2023 in the Class Action Filed on Behalf of Rite Aid Corporation Shareholders
RAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 19, 2023 in the Class Action... See more »
March 27, 2023
MarketScreener
Taro Pharmaceutical Industries : Report Of Foreign Private Issuer - Form 6-K
(marketscreener.com) HAWTHORNE, N.Y., USA, March 27, 2023 ─ As previously disclosed, on March 1, 2023... See more »
March 27, 2023Insurance Journal
Ransomware Attack to Hit Revenue at India's Top Drugmaker
Sun Pharmaceutical Industries Ltd. expects revenue to fall as measures taken by India's top drugmaker... See more »
March 27, 2023Pharmabiz
Lupin announces completion of pharmacovigilance inspection by US FDA with no observations
Global pharma major Lupin Limited (Lupin) announced that the United States Food and Drug Administrati... See more »
March 27, 2023Mass Market Retailers
Andre Persaud leaves Rite Aid post
CAMP HILL, Pa. - Andre Persaud, chief retail officer at Rite Aid Corp., left the company earlier this... See more »
March 27, 2023Techstory
Sun Pharma says business affected due to ransomware attack on March 2 The ransomware incident has disrupted Sun Pharma's business activities.
The biggest pharmaceutical company in India, Sun Pharmaceuticals Industries Ltd., revealed that a rec... See more »
March 27, 2023The Economic Times
Lupin gets tentative USFDA approval to market generic valbenazine capsules
These are the generic equivalent of Ingrezza capsules, 40 mg, 60 mg, and 80 mg, of Neurocrine Bioscie... See more »
Dr.Reddy's is an India-based multinational pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates.
Read more